Thymulin

Thymulin is a zinc-dependent nonapeptide hormone secreted by thymic epithelial cells, first characterized by Bach et al. in 1977. It is only biologically active when complexed with zinc. Thymulin plays a central role in T-cell maturation and immune modulation, with circulating levels declining sharply with age and zinc deficiency.

Thymulin binds receptors on immature thymocytes, mature T cells, and NK cells to promote T-cell differentiation and enhance cytotoxic activity. Its zinc-binding site (involving N-terminal pyroglutamate, Ser-4, Gln-5, and Ser-8) is required for receptor recognition. Thymulin stimulates IL-2 production, enhances NK cell killing capacity, and restores antibody avidity in aged or thymectomized animals. It modulates the Th1/Th2 cytokine balance and influences neuroendocrine-immune crosstalk.

Animal studies show thymulin restores immune function in aged rodents and thymectomized models, improving antibody production, skin graft rejection responses, and delayed-type hypersensitivity. Zinc supplementation can restore biological activity of circulating thymulin in zinc-deficient subjects. Human clinical trials are limited; most evidence remains preclinical. Research into thymulin gene therapy for pain modulation is ongoing.

Peptides commonly paired with Thymulin for synergistic effects.